Abstract Ankaferd hemostat (ABS; Ankaferd Blood Stopper®, İstanbul, Turkey) is a hemostatic agent having an impact on red blood cell-fibrinogen interactions. The hemostatic …
S Turk, UY Malkan, M Ghasemi… - SAGE open …, 2017 - journals.sagepub.com
Objective: Ankaferd hemostat is the first topical hemostatic agent about the red blood cell– fibrinogen relations tested in the clinical trials. Ankaferd hemostat consists of standardized …
M Mumcuoglu, DF Akin, U Ezer, N Akar - Egyptian Journal of Medical …, 2015 - ajol.info
Background: Ankaferd Blood Stopper (ABS) is a preparation of plant extracts originally used as a hemostatic agent. It has pleiotropic effects in many cellular processes such as cell cycle …
Introduction. Ankaferd hemostat (ABS) is the first topical haemostatic agent involving the red blood cell‐fibrinogen interactions. The antihemorrhagic efficacy of ABS has been tested in …
G Cancan, S Teksoz, E Aytac, AE Arikan… - Journal of …, 2014 - Taylor & Francis
ABSTRACT Background: Ankaferd (Ankaferd blood stopper®, ABS) is a recently developed topical hemostatic agent. ABS is a standardized mixture of the plants Thymus vulgaris …
ABS (Ankaferd Hemostat) has emerged as a novel haemostatic agent of plant origin. Its ability to interact with entire proteins including cell surface receptors and/or blood proteins …
MH Atay, NA ASLAN, S Aktimur… - … of Hematology & …, 2015 - researchgate.net
Oral mucositis, characterized by ulcerative lesions in the oral mucosa of patients undergoing chemotherapy, is currently considered to be the most severe complication of anti-cancer …
R Ciftciler, AE Ciftciler, UY Malkan… - SAGE Open …, 2020 - journals.sagepub.com
Ankaferd hemostat (Ankaferd blood stopper [ABS], Istanbul, Turkey) is a hemostatic agent affecting red blood cell-fibrinogen interactions. ABS has been traditionally used in Anatolia …
Although, Ankaferd hemostat (Ankaferd Blood Stopper, ABS) could be utilized successfully as hemostatic agent, studies demonstrated that it has cytotoxic effects on cells. However, the …